SOFIE’s Phase 2 FAPI Study Outcomes Showcased at ASCO GI 2026
Results from SOFIE’s Phase 2 diagnostic study on [18F]FAPI-74 PET were presented to the oncological […]
Results from SOFIE’s Phase 2 diagnostic study on [18F]FAPI-74 PET were presented to the oncological […]
A WORD FROM OUR CHIEF SCIENTIFIC OFFICER
Dear FAPI […]
Sherly Mosessian, PhD, SOFIE’s Chief Scientific Officer, has been recognized by the […]
Adrien Holzgreve, Lena M Unterrainer, Kimberly Flores, Ethan C Lam, Christine E Mona, Johannes Czernin, […]
William McGahan, Alexa Chadwick, Karen Lindsay, Brook Gulhane, Melissa J Latter, Thomas O’Rourke, Paul A […]
Sajjad Sadeghpour, Atena Aghaee, Hojjat Ahmadzadehfar, Alessio Rizzo, Giorgio Treglia, Ramin Sadeghi
A WORD FROM OUR CHIEF SCIENTIFIC OFFICER
Kim M Pabst, Manuel M Weber, Christina Laschinsky, Patrick Sandach, Timo Bartel, Alina T Küper, […]
Helena Lanzafame, Christoph E Heilig, Eva Wardelmann, Mélanie Desaulniers, Kim Magaly Pabst, Ilektra Antonia Mavroeidi, […]
D Ufton, J Heilinger, H Weis, T Fischer, K Schomäcker, C Bruns, G Dieplinger, H […]